Robert Kim - Feb 7, 2024 Form 3/A Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Medical Officer
Signature
/s/ Scott Bizily, Attorney-in-Fact for Robert Kim
Stock symbol
FDMT
Transactions as of
Feb 7, 2024
Transactions value $
$0
Form type
3/A
Date filed
2/7/2024, 07:42 PM
Date Of Original Report
Apr 5, 2023
Previous filing
Feb 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FDMT Common Stock 1.6K Feb 7, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 3 for the Reporting Person, filed on April 5, 2023 (the "Original Form 3"), is being amended to report common stock held by the reporting person that was acquired prior to the filing of the Original Form 3 and that was inadvertently excluded.